Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West London

PURPOSE: To evaluate the clinical outcomes of patients with treatment–naïve diabetic macula oedema (DMO) treated with Aflibercept in routine clinic settings in ethnically diverse North West London (NWL) and compare to outcomes reported in the VIVID and VISTA clinical trials METHODS: This was a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinah, Christiana, Ghulakhszian, Arevik, Sim, Sing Yue, Minocha, Amal, Nokhostin, Soroush, Posner, Esther, Cheong-Lee, Richard, George, Sheena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877641/
https://www.ncbi.nlm.nih.gov/pubmed/33571295
http://dx.doi.org/10.1371/journal.pone.0246626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877641/
https://www.ncbi.nlm.nih.gov/pubmed/33571295
http://dx.doi.org/10.1371/journal.pone.0246626

Ejemplares similares